Stocks / NASDAQ / Skye Bioscience Inc.

Skye Bioscience Inc.

Industry: Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol: SKYE – NASDAQ

Animal Usage: Animal Testing

Our Opinion

Skye Bioscience Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company confirms in corporate disclosures that it utilizes animal subjects for product testing.

“Results from this quantitative assay demonstrated SBI-100 treated animals showed a mean trend of higher function of RCGs compared to untreated animals.” Read the following article

Company Description

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.

Company Website: https://www.skyebioscience.com

Contact: ir@skyebioscience.com